Related Experiment Video
Updated: Jun 1, 2026
Site-Specific Lysine Lactylation via Genetic Code Expansion in E. coli and Mammalian Cells
Published on: February 24, 2026
Lactylation-augmented DCBLD1-mediated PDIA3 stabilization reprograms glycolysis metabolism in oesophageal cancer
Ming Yin1,2, Shan Wang2, HaiMin Liu2
1Department of Cardiothoracic Surgery, The Yancheng Clinical College of Xuzhou Medical University, The First People's Hospital of Yancheng City, No. 66 Renmin South Road, Yancheng, 224005, Jiangsu, People's Republic of China.
Objective:
Histone lactylation (Hla) represents a novel epigenetic mark priming cells toward the malignant state. Discoidin, CUB, and LCCL domain-containing type I (DCBLD1) has been reported as a carcinogenic gene so far. This project was focused on the functional role of DCBLD1 in oesophageal cancer through the lactate modification pathway.
Methods:
Biological information evaluated DCBLD1, protein disulfide isomerase family A member 3 (PDIA3) expression and the relationship between the two in oesophageal cancer. RT-qPCR and Western blotting were used to detect DCBLD1 and PDIA3 expression. Western blotting also quantified DCBLD1-lysine lactylation (kla) levels. DCBLD1 half-life was checked by chlorhexidine (CHX) assay. EDU, wound healing, transwell, flow cytometry and Seahorse assays individually appraised cell proliferation, migration, apoptosis and glycolysis. Co-IP assay identified DCBLD1-PDIA3 interaction. Xenografted tumorigenesis was estimated, prior to histological assessment by H&E staining. Glucose consumption and lactate production were also examined to detect glycolysis.
Results:
DCBLD1 was highly expressed in esophageal cancer specimens and cells. DCBLD1 half-life was respectively shortened or prolonged in tumor cells challenged with lactate (LA) or the aerobic glycolysis inhibitor 2-deoxy-d-glucose (2-DG). DCBLD1-Kla levels were up-regulated in oesophageal cancer tissues. Lactate dehydrogenase A (LDHA) interference decreased both DCBLD1 expression and DCBLD1-Kla expression. PDIA3 was highly expressed in oesophageal cancer. DCBLD1 was positively correlated with, and interacted with PDIA3 upon LA stimulation. DCBLD1 knockdown inhibited cell proliferation, migration, glycolysis and induced apoptosis, repressed tumor progress and glycolysis in vivo, which were all partially recovered by PDIA3 overexpression. Further LDHA down-regulation aggravated the impacts of DCBLD1 knockdown and PDIA3 overexpression both in vitro and in vivo.
Conclusion:
It was established that DCBLD1 lactylation bound to PDIA3, contributing to oesophageal cancer malignancy and glycolysis.
